Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 197

1.

LDL-Cholesterol Lowering of Plant Sterols and Stanols-Which Factors Influence Their Efficacy?

Trautwein EA, Vermeer MA, Hiemstra H, Ras RT.

Nutrients. 2018 Sep 7;10(9). pii: E1262. doi: 10.3390/nu10091262. Review.

2.

Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides.

Bastidas Torres AN, Cats D, Mei H, Szuhai K, Willemze R, Vermeer MH, Tensen CP.

Genes Chromosomes Cancer. 2018 Aug 25. doi: 10.1002/gcc.22679. [Epub ahead of print]

PMID:
30144205
3.

High Incidence and Clinical Significance of MYC Rearrangements in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.

Schrader AMR, Jansen PM, Vermeer MH, Kleiverda JK, Vermaat JSP, Willemze R.

Am J Surg Pathol. 2018 Aug 14. doi: 10.1097/PAS.0000000000001132. [Epub ahead of print]

PMID:
30113335
4.

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.

Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, Whittaker S, Tokura Y, Vermeer M, Zinzani PL, Sokol L, Morris S, Kim EJ, Ortiz-Romero PL, Eradat H, Scarisbrick J, Tsianakas A, Elmets C, Dalle S, Fisher DC, Halwani A, Poligone B, Greer J, Fierro MT, Khot A, Moskowitz AJ, Musiek A, Shustov A, Pro B, Geskin LJ, Dwyer K, Moriya J, Leoni M, Humphrey JS, Hudgens S, Grebennik DO, Tobinai K, Duvic M; MAVORIC Investigators.

Lancet Oncol. 2018 Sep;19(9):1192-1204. doi: 10.1016/S1470-2045(18)30379-6. Epub 2018 Aug 9.

PMID:
30100375
5.

Developments in the understanding of blood involvement and stage in mycosis fungoides/Sezary syndrome.

Scarisbrick JJ, Hodak E, Bagot M, Stranzenbach R, Stadler R, Ortiz-Romero PL, Papadavid E, Knobler R, Quaglino P, Vermeer M.

Eur J Cancer. 2018 Sep;101:278-280. doi: 10.1016/j.ejca.2018.06.013. Epub 2018 Jul 13. No abstract available.

PMID:
30017383
6.

An Integrated Data Resource for Genomic Analysis of Cutaneous T-Cell Lymphoma.

Chang LW, Patrone CC, Yang W, Rabionet R, Gallardo F, Espinet B, Sharma MK, Girardi M, Tensen CP, Vermeer M, Geskin LJ.

J Invest Dermatol. 2018 Jul 5. pii: S0022-202X(18)32294-2. doi: 10.1016/j.jid.2018.06.176. [Epub ahead of print] No abstract available.

PMID:
29981755
7.

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.

Quaglino P, Maule M, Prince HM, Porcu P, Horwitz S, Duvic M, Talpur R, Vermeer M, Bagot M, Guitart J, Papadavid E, Sanches JA, Hodak E, Sugaya M, Berti E, Ortiz-Romero P, Pimpinelli N, Servitje O, Pileri A, Zinzani PL, Estrach T, Knobler R, Stadler R, Fierro MT, Alberti Violetti S, Amitay-Laish I, Antoniou C, Astrua C, Chaganti S, Child F, Combalia A, Fabbro S, Fava P, Grandi V, Jonak C, Martinez-Escala E, Kheterpal M, Kim EJ, McCormack C, Miyagaki T, Miyashiro D, Morris S, Muniesa C, Nikolaou V, Ognibene G, Onida F, Osella-Abate S, Porkert S, Postigo-Llorente C, Ram-Wolff C, Ribero S, Rogers K, Sanlorenzo M, Stranzenbach R, Spaccarelli N, Stevens A, Zugna D, Rook AH, Geskin LJ, Willemze R, Whittaker S, Hoppe R, Scarisbrick J, Kim Y.

Ann Oncol. 2018 Jun 26. doi: 10.1093/annonc/mdy207. [Epub ahead of print] No abstract available.

PMID:
29947731
8.

Plant sterols lower LDL-cholesterol and triglycerides in dyslipidemic individuals with or at risk of developing type 2 diabetes; a randomized, double-blind, placebo-controlled study.

Trautwein EA, Koppenol WP, de Jong A, Hiemstra H, Vermeer MA, Noakes M, Luscombe-Marsh ND.

Nutr Diabetes. 2018 May 25;8(1):30. doi: 10.1038/s41387-018-0039-8.

9.

Cardiomyopathy in patients with epidermolysis bullosa simplex with mutations in KLHL24.

Yenamandra VK, van den Akker PC, Lemmink HH, Jan SZ, Diercks GFH, Vermeer M, van den Berg MP, van der Meer P, Pasmooij AMG, Sinke RJ, Jonkman MF, Bolling MC.

Br J Dermatol. 2018 May 19. doi: 10.1111/bjd.16797. [Epub ahead of print] No abstract available.

PMID:
29779254
10.

CSF1R-dependent myeloid cells are required for NK‑mediated control of metastasis.

Beffinger M, Tallón de Lara P, Tugues S, Vermeer M, Montagnolo Y, Ohs I, Cecconi V, Lucchiari G, Gagliardi A, Misljencevic N, Sutton J, Spörri R, Becher B, Gupta A, van den Broek M.

JCI Insight. 2018 May 17;3(10). pii: 97792. doi: 10.1172/jci.insight.97792. [Epub ahead of print]

11.

Molecular advances in cutaneous T-cell lymphoma.

Bastidas Torres AN, Najidh S, Tensen CP, Vermeer MH.

Semin Cutan Med Surg. 2018 Mar;37(1):81-86. doi: 10.12788/j.sder.2018.007.

PMID:
29719024
12.

Novel regulations of the angiotensin II receptor type 1 by calmodulin.

Ehlers K, Clements R, VerMeer M, Giles J, Tran QK.

Biochem Pharmacol. 2018 Jun;152:187-200. doi: 10.1016/j.bcp.2018.03.027. Epub 2018 Mar 30.

PMID:
29605626
13.

Totally minimally invasive esophagectomy after neoadjuvant chemoradiotherapy: Long-term oncologic outcomes.

Lubbers M, van Det MJ, Kreuger MJ, Hoekstra R, Hendriksen EM, Vermeer M, Kouwenhoven EA.

J Surg Oncol. 2018 Mar;117(4):651-658. doi: 10.1002/jso.24935.

PMID:
29603271
14.

High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma.

Schrader AMR, Jansen PM, Willemze R, Vermeer MH, Cleton-Jansen AM, Somers SF, Veelken H, van Eijk R, Kraan W, Kersten MJ, van den Brand M, Stevens WBC, de Jong D, Abdul Hamid M, Tanis BC, Posthuma EFM, Nijland M, Diepstra A, Pals ST, Cleven AHG, Vermaat JSP.

Blood. 2018 May 3;131(18):2086-2089. doi: 10.1182/blood-2017-12-822817. Epub 2018 Mar 7. No abstract available.

PMID:
29514783
15.

Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: report of the Dutch Cutaneous Lymphoma Group.

Melchers RC, Willemze R, Bekkenk MW, de Haas ERM, Horvath B, van Rossum MM, Sanders CJG, Veraart JCJM, Vermeer MH, Quint KD.

Br J Dermatol. 2018 Sep;179(3):724-731. doi: 10.1111/bjd.16501. Epub 2018 Jun 21.

PMID:
29494757
16.

Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force.

Scarisbrick JJ, Hodak E, Bagot M, Stranzenbach R, Stadler R, Ortiz-Romero PL, Papadavid E, Evison F, Knobler R, Quaglino P, Vermeer MH.

Eur J Cancer. 2018 Apr;93:47-56. doi: 10.1016/j.ejca.2018.01.076. Epub 2018 Feb 21. Review.

17.

Correction: Variability and cost implications of three generations of the Roche LightCycler® 480.

Dullaert-de Boer M, Akkerman OW, Vermeer M, Hess DLJ, Kerstjens HAM, Anthony RM, van der Werf TS, van Soolingen D, van der Zanden AGM.

PLoS One. 2018 Feb 9;13(2):e0192946. doi: 10.1371/journal.pone.0192946. eCollection 2018.

18.

Variability and cost implications of three generations of the Roche LightCycler® 480.

Dullaert-de Boer M, Akkerman OW, Vermeer M, Hess DLJ, Kerstjens HAM, Anthony RM, van der Werf TS, van Soolingen D, van der Zanden AGM.

PLoS One. 2018 Jan 12;13(1):e0190847. doi: 10.1371/journal.pone.0190847. eCollection 2018. Erratum in: PLoS One. 2018 Feb 9;13(2):e0192946.

19.

Folliculotropic mycosis fungoides presenting with a solitary lesion: Clinicopathological features and long-term follow-up data in a series of 9 cases.

van Santen S, Jansen PM, Vermeer MH, Willemze R.

J Cutan Pathol. 2018 Feb;45(2):122-128. doi: 10.1111/cup.13077. Epub 2017 Dec 11.

PMID:
29086994
20.

Special variant of histiocytosis.

Quint KD, Cleven AH, Vermeer MH.

BMJ Case Rep. 2017 Oct 25;2017. pii: bcr-2017-221538. doi: 10.1136/bcr-2017-221538.

PMID:
29070620
21.

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.

Quaglino P, Maule M, Prince HM, Porcu P, Horwitz S, Duvic M, Talpur R, Vermeer M, Bagot M, Guitart J, Papadavid E, Sanches JA, Hodak E, Sugaya M, Berti E, Ortiz-Romero P, Pimpinelli N, Servitje O, Pileri A, Zinzani PL, Estrach T, Knobler R, Stadler R, Fierro MT, Alberti Violetti S, Amitay-Laish I, Antoniou C, Astrua C, Chaganti S, Child F, Combalia A, Fabbro S, Fava P, Grandi V, Jonak C, Martinez-Escala E, Kheterpal M, Kim EJ, McCormack C, Miyagaki T, Miyashiro D, Morris S, Muniesa C, Nikolaou V, Ognibene G, Onida F, Osella-Abate S, Porkert S, Postigo-Llorente C, Ram-Wolff C, Ribero S, Rogers K, Sanlorenzo M, Stranzenbach R, Spaccarelli N, Stevens A, Zugna D, Rook AH, Geskin LJ, Willemze R, Whittaker S, Hoppe R, Scarisbrick J, Kim Y.

Ann Oncol. 2017 Oct 1;28(10):2517-2525. doi: 10.1093/annonc/mdx352.

PMID:
28961843
22.

Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group.

Melchers RC, Willemze R, Daniëls LA, Neelis KJ, Bekkenk MW, de Haas ERM, Horvath B, van Rossum MM, Sanders CJG, Velstra B, Veraart JCJM, Roach REJ, Vermeer MH, Quint KD.

Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1279-1285. doi: 10.1016/j.ijrobp.2017.08.010. Epub 2017 Aug 24.

PMID:
28958772
23.

MicroRNA-155 potentiates tumour development in mycosis fungoides.

Tensen CP, Vermeer MH.

Br J Dermatol. 2017 Sep;177(3):618-620. doi: 10.1111/bjd.15785. No abstract available.

PMID:
28940265
24.

Suppression of store-operated Ca2+ entry by activation of GPER: contribution to a clamping effect on endothelial Ca2+ signaling.

Terry LE, VerMeer M, Giles J, Tran QK.

Biochem J. 2017 Oct 23;474(21):3627-3642. doi: 10.1042/BCJ20170630.

PMID:
28935720
25.

A novel keratin 13 variant in a four-generation family with white sponge nevus.

de Haseth SB, Bakker E, Vermeer MH, El Idrissi H, Bosse T, Smit VTHBM, Terron-Kwiatkowski A, McLean WHI, Peters AAW, Hes FJ.

Clin Case Rep. 2017 Jul 29;5(9):1503-1509. doi: 10.1002/ccr3.1073. eCollection 2017 Sep.

26.

Genetic rearrangements result in altered gene expression and novel fusion transcripts in Sézary syndrome.

Iżykowska K, Przybylski GK, Gand C, Braun FC, Grabarczyk P, Kuss AW, Olek-Hrab K, Bastidas Torres AN, Vermeer MH, Zoutman WH, Tensen CP, Schmidt CA.

Oncotarget. 2017 Jun 13;8(24):39627-39639. doi: 10.18632/oncotarget.17383.

27.

A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs.

Bagot M, Hasan B, Whittaker S, Beylot-Barry M, Knobler R, Shah E, Marreaud S, Morris S, Dalle S, Servitje O, Cowan R, Väkevä L, Chaby G, Jonak C, Fox CP, Ritchie D, Vermeer MH, Stadler R, Romero PLO, Scarisbrick J, Quaglino P.

Eur J Dermatol. 2017 Jun 1;27(3):286-294. doi: 10.1684/ejd.2017.3008.

PMID:
28468739
28.

European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.

Trautinger F, Eder J, Assaf C, Bagot M, Cozzio A, Dummer R, Gniadecki R, Klemke CD, Ortiz-Romero PL, Papadavid E, Pimpinelli N, Quaglino P, Ranki A, Scarisbrick J, Stadler R, Väkevä L, Vermeer MH, Whittaker S, Willemze R, Knobler R.

Eur J Cancer. 2017 May;77:57-74. doi: 10.1016/j.ejca.2017.02.027. Epub 2017 Mar 31. Review.

29.

Recommendations for treatment in folliculotropic mycosis fungoides: report of the Dutch Cutaneous Lymphoma Group.

van Santen S, van Doorn R, Neelis KJ, Daniëls LA, Horváth B, Bruijn MS, Sanders CJG, van Rossum MM, de Haas ERM, Veraart JCJM, Bekkenk MW, Vermeer MH, Willemze R.

Br J Dermatol. 2017 Jul;177(1):223-228. doi: 10.1111/bjd.15355. Epub 2017 May 11.

PMID:
28132406
30.

Accurate Quantification of T Cells by Measuring Loss of Germline T-Cell Receptor Loci with Generic Single Duplex Droplet Digital PCR Assays.

Zoutman WH, Nell RJ, Versluis M, van Steenderen D, Lalai RN, Out-Luiting JJ, de Lange MJ, Vermeer MH, Langerak AW, van der Velden PA.

J Mol Diagn. 2017 Mar;19(2):236-243. doi: 10.1016/j.jmoldx.2016.10.006. Epub 2016 Dec 22.

PMID:
28012713
31.

Increased Expression of PLS3 Correlates with Better Outcome in Sézary Syndrome.

Boonk SE, Zoutman WH, Putter H, Ram-Wolff C, Felcht M, Klemke CD, Ranki A, Quaglino P, Whittaker S, Bagot M, Willemze R, Vermeer MH.

J Invest Dermatol. 2017 Mar;137(3):754-757. doi: 10.1016/j.jid.2016.10.025. Epub 2016 Oct 28. No abstract available.

32.

The clinical spectrum of mycosis fungoides in Tanzania, East Africa.

Grijsen ML, Mtayangulwa RG, Naafs B, Jansen P, Vermeer MH, Mavura D, Masenga EJ, Willemze R.

Br J Dermatol. 2017 Jun;176(6):1653-1656. doi: 10.1111/bjd.14963. Epub 2017 Mar 28. No abstract available.

PMID:
27529394
33.

Prediction of early mortality following hip fracture surgery in frail elderly: The Almelo Hip Fracture Score (AHFS).

Nijmeijer WS, Folbert EC, Vermeer M, Slaets JP, Hegeman JH.

Injury. 2016 Oct;47(10):2138-2143. doi: 10.1016/j.injury.2016.07.022. Epub 2016 Jul 20.

PMID:
27469403
34.

Improved 1-year mortality in elderly patients with a hip fracture following integrated orthogeriatric treatment.

Folbert EC, Hegeman JH, Vermeer M, Regtuijt EM, van der Velde D, Ten Duis HJ, Slaets JP.

Osteoporos Int. 2017 Jan;28(1):269-277. doi: 10.1007/s00198-016-3711-7. Epub 2016 Jul 21.

PMID:
27443570
35.

Clinical Staging and Prognostic Factors in Folliculotropic Mycosis Fungoides.

van Santen S, Roach RE, van Doorn R, Horváth B, Bruijn MS, Sanders CJ, de Pooter JC, van Rossum MM, de Haas ER, Veraart JC, Bekkenk MW, Vermeer MH, Willemze R.

JAMA Dermatol. 2016 Sep 1;152(9):992-1000. doi: 10.1001/jamadermatol.2016.1597.

PMID:
27276223
36.

Epigenomic Analysis of Sézary Syndrome Defines Patterns of Aberrant DNA Methylation and Identifies Diagnostic Markers.

van Doorn R, Slieker RC, Boonk SE, Zoutman WH, Goeman JJ, Bagot M, Michel L, Tensen CP, Willemze R, Heijmans BT, Vermeer MH.

J Invest Dermatol. 2016 Sep;136(9):1876-84. doi: 10.1016/j.jid.2016.03.042. Epub 2016 Apr 23. Review.

37.

Estrogen Enhances Linkage in the Vascular Endothelial Calmodulin Network via a Feedforward Mechanism at the G Protein-coupled Estrogen Receptor 1.

Tran QK, Firkins R, Giles J, Francis S, Matnishian V, Tran P, VerMeer M, Jasurda J, Burgard MA, Gebert-Oberle B.

J Biol Chem. 2016 May 13;291(20):10805-23. doi: 10.1074/jbc.M115.697334. Epub 2016 Mar 17.

38.

Evaluation of Immunophenotypic and Molecular Biomarkers for Sézary Syndrome Using Standard Operating Procedures: A Multicenter Study of 59 Patients.

Boonk SE, Zoutman WH, Marie-Cardine A, van der Fits L, Out-Luiting JJ, Mitchell TJ, Tosi I, Morris SL, Moriarty B, Booken N, Felcht M, Quaglino P, Ponti R, Barberio E, Ram-Wolff C, Jäntti K, Ranki A, Bernengo MG, Klemke CD, Bensussan A, Michel L, Whittaker S, Bagot M, Tensen CP, Willemze R, Vermeer MH.

J Invest Dermatol. 2016 Jul;136(7):1364-1372. doi: 10.1016/j.jid.2016.01.038. Epub 2016 Feb 28.

39.

Score test for association between recurrent events and a terminal event.

Balan TA, Boonk SE, Vermeer MH, Putter H.

Stat Med. 2016 Aug 15;35(18):3037-48. doi: 10.1002/sim.6913. Epub 2016 Feb 17.

PMID:
26891109
40.

[A toddler with an itchy, brown rash].

Mulder KM, Vermeer MH.

Ned Tijdschr Geneeskd. 2016;160:A9630. Dutch.

PMID:
26786799
41.

The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.

da Silva Almeida AC, Abate F, Khiabanian H, Martinez-Escala E, Guitart J, Tensen CP, Vermeer MH, Rabadan R, Ferrando A, Palomero T.

Nat Genet. 2015 Dec;47(12):1465-70. doi: 10.1038/ng.3442. Epub 2015 Nov 9.

42.

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.

Scarisbrick JJ, Prince HM, Vermeer MH, Quaglino P, Horwitz S, Porcu P, Stadler R, Wood GS, Beylot-Barry M, Pham-Ledard A, Foss F, Girardi M, Bagot M, Michel L, Battistella M, Guitart J, Kuzel TM, Martinez-Escala ME, Estrach T, Papadavid E, Antoniou C, Rigopoulos D, Nikolaou V, Sugaya M, Miyagaki T, Gniadecki R, Sanches JA, Cury-Martins J, Miyashiro D, Servitje O, Muniesa C, Berti E, Onida F, Corti L, Hodak E, Amitay-Laish I, Ortiz-Romero PL, Rodríguez-Peralto JL, Knobler R, Porkert S, Bauer W, Pimpinelli N, Grandi V, Cowan R, Rook A, Kim E, Pileri A, Patrizi A, Pujol RM, Wong H, Tyler K, Stranzenbach R, Querfeld C, Fava P, Maule M, Willemze R, Evison F, Morris S, Twigger R, Talpur R, Kim J, Ognibene G, Li S, Tavallaee M, Hoppe RT, Duvic M, Whittaker SJ, Kim YH.

J Clin Oncol. 2015 Nov 10;33(32):3766-73. doi: 10.1200/JCO.2015.61.7142. Epub 2015 Oct 5.

43.

EPHA4 is overexpressed but not functionally active in Sézary syndrome.

Hameetman L, van der Fits L, Zoutman WH, Out-Luiting JJ, Siegal G, de Esch IJ, Vermeer MH, Tensen CP.

Oncotarget. 2015 Oct 13;6(31):31868-76. doi: 10.18632/oncotarget.5573.

44.

Microarray Techniques to Analyze Copy-Number Alterations in Genomic DNA: Array Comparative Genomic Hybridization and Single-Nucleotide Polymorphism Array.

Szuhai K, Vermeer M.

J Invest Dermatol. 2015 Oct;135(10):e37. doi: 10.1038/jid.2015.308. Review. No abstract available.

45.

Prediction and Synthesis of Strain Tolerant RbCuTe Crystals Based on Rotation of One-Dimensional Nano Ribbons within a Three-Dimensional Inorganic Network.

Vermeer MJ, Zhang X, Trimarchi G, Donakowski MD, Chupas PJ, Poeppelmeier KR, Zunger A.

J Am Chem Soc. 2015 Sep 9;137(35):11383-90. doi: 10.1021/jacs.5b06182. Epub 2015 Aug 27.

PMID:
26274577
46.

Recommendations for treatment of lymphomatoid papulosis with methotrexate: a report from the Dutch Cutaneous Lymphoma Group.

Bruijn MS, Horváth B, van Voorst Vader PC, Willemze R, Vermeer MH.

Br J Dermatol. 2015 Nov;173(5):1319-22. doi: 10.1111/bjd.13920. Epub 2015 Oct 8. No abstract available.

PMID:
25998985
47.

Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases.

Klemke CD, Booken N, Weiss C, Nicolay JP, Goerdt S, Felcht M, Géraud C, Kempf W, Assaf C, Ortonne N, Battistella M, Bagot M, Knobler R, Quaglino P, Arheiliger B, Santucci M, Jansen P, Vermeer MH, Willemze R.

Br J Dermatol. 2015 Jul;173(1):93-105. doi: 10.1111/bjd.13832. Epub 2015 Jun 23.

48.

Hetero-oligomeric Complex between the G Protein-coupled Estrogen Receptor 1 and the Plasma Membrane Ca2+-ATPase 4b.

Tran QK, VerMeer M, Burgard MA, Hassan AB, Giles J.

J Biol Chem. 2015 May 22;290(21):13293-307. doi: 10.1074/jbc.M114.628743. Epub 2015 Apr 6.

49.

Differential expression of TOX by skin-infiltrating T cells in Sézary syndrome and erythrodermic dermatitis.

Boonk SE, Çetinözman F, Vermeer MH, Jansen PM, Willemze R.

J Cutan Pathol. 2015 Sep;42(9):604-9. doi: 10.1111/cup.12490. Epub 2015 May 6.

PMID:
25777533
50.

Limited effect of chemotherapy in cutaneous lymphoma.

Vermeer MH, Willemze R.

Blood. 2015 Jan 1;125(1):4-5. doi: 10.1182/blood-2014-11-609305. No abstract available.

Supplemental Content

Loading ...
Support Center